Y-Intercept (HK)’s Edwards Lifesciences EW Stock Holding History

Y-Intercept (HK)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.36M	Sell	15,782 -20,260	-56%	-$1.8M	0.03%	829
2026 Q2	$3.26M	Buy	+36,042	New	+$3.02M	0.06%	448
2026 Q1	–	Sell	-9,550	Closed	-$814K	–	1696
2025 Q4	$814K	Buy	+9,550	New	+$784K	0.02%	1073
2025 Q3	–	Sell	-168,378	Closed	-$13.2M	–	1700
2025 Q2	$13.2M	Buy	168,378 +141,843	+535%	+$10.6M	0.32%	38
2025 Q1	$1.92M	Sell	26,535 -11,686	-31%	-$836K	0.13%	197
2024 Q4	$2.83M	Buy	38,221 +24,398	+177%	+$1.71M	0.19%	138
2024 Q3	$912K	Sell	13,823 -3,122	-18%	-$227K	0.06%	487
2024 Q2	$1.57M	Buy	+16,945	New	+$1.5M	0.09%	325
2024 Q1	–	Sell	-13,034	Closed	-$994K	–	1480
2023 Q4	$994K	Sell	13,034 -48,441	-79%	-$3.37M	0.09%	320
2023 Q3	$4.26M	Buy	61,475 +44,860	+270%	+$3.6M	0.42%	27
2023 Q2	$1.57M	Buy	16,615 +7,893	+90%	+$686K	0.17%	155
2023 Q1	$722K	Sell	8,722 -10,324	-54%	-$812K	0.08%	369
2022 Q4	$1.42M	Sell	19,046 -22,190	-54%	-$1.71M	0.21%	113
2022 Q3	$3.41M	Buy	+41,236	New	+$3.97M	0.34%	50
2021 Q4	–	Sell	-22,795	Closed	-$2.58M	–	659
2021 Q3	$2.58M	Buy	+22,795	New	+$2.6M	0.47%	28

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Y-Intercept (HK)'s EW Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Edwards Lifesciences (EW) stake by 56% in Q3 2026, selling an estimated $1.8M and leaving 15,782 shares worth $1.36M. The position accounts for 0.03% of the portfolio, ranked #829.

Y-Intercept (HK) first reported a position in EW in Q3 2021 and has held it in 15 quarters since. The position peaked at $13.2M in Q2 2025. 326 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Y-Intercept (HK) held 15,782 shares of Edwards Lifesciences worth $1.36M as of Q3 2026.
Y-Intercept (HK) sold 20,260 Edwards Lifesciences shares in Q3 2026, an estimated $1.8M.
Edwards Lifesciences made up 0.03% of Y-Intercept (HK)'s portfolio in Q3 2026, its #829 holding.
Y-Intercept (HK) first reported a position in Edwards Lifesciences in Q3 2021 and has held it in 15 quarters since.
Y-Intercept (HK)'s Edwards Lifesciences position peaked at $13.2M in Q2 2025.
326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.